← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Ventas, Inc. (VTR) 10-Year Financial Performance & Capital Metrics

VTR • • REIT / Real Estate
Real EstateHealthcare REITsDiversified Healthcare REITsMulti-Sector Healthcare REITs
AboutVentas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.Show more
  • Revenue $4.92B +9.5%
  • FFO $1.36B -0.7%
  • FFO/Share 3.28 -3.2%
  • FFO Payout 54.26% +3.0%
  • FFO per Share 3.28 -3.2%
  • NOI Margin 42.59% -1.1%
  • FFO Margin 27.71% -9.3%
  • ROE 0.8% +292.1%
  • ROA 0.32% +290.2%
  • Debt/Assets 52.47% -5.2%
  • Net Debt/EBITDA 6.54 -9.2%
  • Book Value/Share 26.01 +10.6%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Strong Piotroski F-Score: 7/9
  • ✓FFO growing 17.5% TTM
  • ✓Sustainable FFO payout ratio of 54.3%
  • ✓Healthy dividend yield of 2.3%

✗Weaknesses

  • ✗Profits declining 28.5% over 5 years
  • ✗Dividend payout exceeds 100% of earnings

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y4.82%
5Y4.92%
3Y8.76%
TTM15.69%

Profit (Net Income) CAGR

10Y-16.21%
5Y-28.46%
3Y18.31%
TTM457.91%

EPS CAGR

10Y-19.19%
5Y-30.48%
3Y13.48%
TTM334.42%

ROCE

10Y Avg2.87%
5Y Avg2.24%
3Y Avg2.24%
Latest2.81%

Peer Comparison

Multi-Sector Healthcare REITs
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
VTRVentas, Inc.36.13B76.92404.849.48%4.28%1.92%2.01%1.27
WELLWelltower Inc.129.15B188.18119.8621.23%9.77%2.45%1.7%0.51
DOCHealthpeak Properties, Inc.12.2B17.5548.7523.82%-1.24%-0.46%8.78%1.00

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Revenue+3.29B3.44B3.57B3.75B3.87B3.8B3.83B4.13B4.5B4.92B
Revenue Growth %0.07%0.05%0.04%0.05%0.03%-0.02%0.01%0.08%0.09%0.09%
Property Operating Expenses1.41B1.44B1.49B1.69B1.81B1.94B2.09B2.28B2.56B2.83B
Net Operating Income (NOI)+----------
NOI Margin %----------
Operating Expenses+1.02B1.03B1.02B1.07B1.2B1.26B1.32B1.36B1.52B1.42B
G&A Expenses128.03M126.88M135.49M151.98M158.73M130.16M129.76M144.87M148.88M162.99M
EBITDA+1.81B3B3.12B3.66B1.93B1.72B1.64B1.69B1.83B1.96B
EBITDA Margin %----------
Depreciation & Amortization+979.11M2.44B2.5B2.8B1.07B1.13B1.22B1.21B1.41B1.28B
D&A / Revenue %----------
Operating Income+834.72M556.79M622.09M861.09M857.88M591.44M421.43M483.85M415.51M681.23M
Operating Margin %----------
Interest Expense+367.11M419.74M448.2M442.5M451.66M469.54M440.09M467.56M574.11M602.84M
Interest Coverage2.27x1.33x1.39x1.95x1.90x1.26x0.96x1.03x0.72x1.13x
Non-Operating Income-248.34M-65.16M195.98M127.09M23.23M-222.75M-80.04M74.15M-118.76M27.82M
Pretax Income+350.25M522.87M584.15M376.04M382.99M344.65M61.39M-57.86M-39.84M50.58M
Pretax Margin %----------
Income Tax+-39.28M-31.34M-59.8M-39.95M-56.31M-96.53M4.83M-16.93M-9.54M-37.77M
Effective Tax Rate %----------
Net Income+417.84M649.23M1.36B409.47M433.02M439.15M49.01M-47.45M-40.97M81.15M
Net Margin %----------
Net Income Growth %-0.12%0.55%1.09%-0.7%0.06%0.01%-0.89%-1.97%0.14%2.98%
Funds From Operations (FFO)+----------
FFO Margin %----------
FFO Growth %0.07%1.21%0.25%-0.17%-0.53%0.05%-0.19%-0.08%0.18%-0.01%
FFO per Share+----------
FFO Payout Ratio %----------
EPS (Diluted)+1.251.863.781.141.171.170.13-0.13-0.100.19
EPS Growth %-0.22%0.49%1.03%-0.7%0.03%0%-0.89%-2%0.23%2.9%
EPS (Basic)1.261.883.821.151.181.180.13-0.13-0.100.20
Diluted Shares Outstanding334.01M348.39M358.57M359.3M369.89M376.5M386.3M373.37M405.67M416.37M

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Assets+22.26B23.17B23.95B22.58B24.69B23.93B24.72B24.16B24.73B26.19B
Asset Growth %0.05%0.04%0.03%-0.06%0.09%-0.03%0.03%-0.02%0.02%0.06%
Real Estate & Other Assets+19.74B20.58B20.81B20.28B21.97B20.82B22.11B21.46B22.13B23.06B
PP&E (Net)0000000000
Investment Securities1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Total Current Assets+1.34B1.42B1.93B1.14B1.52B1.53B951.02M964.59M868.2M1.35B
Cash & Equivalents53.02M286.71M81.36M72.28M106.36M413.33M149.72M122.56M508.79M897.85M
Receivables1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Other Current Assets170.96M135.61M172.31M64.64M125.27M47.92M75.27M93.07M111.16M78.01M
Intangible Assets13.22M8.19M6.5M5.62M5.15M4.66M7.27M6.39M5.58M11.51M
Total Liabilities12.64B12.64B13.02B12.31B14.15B13.65B13.77B13.94B15.18B15.36B
Total Debt+11.21B11.13B11.28B10.73B12.41B12.11B12.22B12.49B13.69B13.74B
Net Debt11.15B10.84B11.19B10.66B12.3B11.69B12.08B12.36B13.18B12.84B
Long-Term Debt11.03B10.98B10.74B9.88B11.31B11.7B11.69B11.87B13.48B13.52B
Short-Term Borrowings1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Capital Lease Obligations0000251.2M209.92M197.23M190.44M194.73M218M
Total Current Liabilities+1.08B1.14B1.88B2.04B2.11B1.44B1.54B1.58B1.18B1.3B
Accounts Payable779.38M907.93M1.18B1.09B1.15B1.13B1.09B1.03B1.04B1.15B
Deferred Revenue0000000000
Other Liabilities196.53M200.73M158.49M188.14M273.68M235.49M280.28M264.65M302.64M310.23M
Total Equity+9.63B10.53B10.93B10.27B10.55B10.28B10.95B10.22B9.54B10.83B
Equity Growth %0.1%0.09%0.04%-0.06%0.03%-0.03%0.06%-0.07%-0.07%0.13%
Shareholders Equity9.56B10.46B10.87B10.22B10.45B10.18B10.85B10.15B9.49B10.77B
Minority Interest61.1M68.51M65.96M55.74M99.56M98.02M91.38M68.71M56.35M58.33M
Common Stock83.58M88.51M89.03M89.13M93.19M93.64M99.84M99.91M100.65M109.12M
Additional Paid-in Capital11.6B12.92B13.05B13.08B14.06B14.17B15.5B15.54B15.65B17.61B
Retained Earnings-2.11B-2.49B-2.24B-2.93B-3.67B-4.03B-4.68B-5.45B00
Preferred Stock0000000000
Return on Assets (ROA)0.02%0.03%0.06%0.02%0.02%0.02%0%-0%-0%0%
Return on Equity (ROE)0.05%0.06%0.13%0.04%0.04%0.04%0%-0%-0%0.01%
Debt / Assets0.5%0.48%0.47%0.48%0.5%0.51%0.49%0.52%0.55%0.52%
Debt / Equity1.16x1.06x1.03x1.04x1.18x1.18x1.12x1.22x1.43x1.27x
Net Debt / EBITDA6.15x3.61x3.59x2.91x6.39x6.79x7.38x7.30x7.20x6.54x
Book Value per Share28.8230.2230.4928.5928.5127.3028.3327.3823.5326.01

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+1.39B1.37B1.44B1.38B1.44B1.45B1.03B1.12B1.12B1.33B
Operating CF Growth %0.11%-0.02%0.05%-0.04%0.04%0.01%-0.29%0.09%-0%0.19%
Operating CF / Revenue %----------
Net Income419.22M651.49M1.36B415.98M439.3M441.19M56.56M-40.93M-30.3M88.35M
Depreciation & Amortization979.11M909.28M904.01M938.52M1.07B1.13B1.22B1.21B1.41B1.28B
Stock-Based Compensation19.54M20.96M26.54M29.96M33.92M21.49M31.97M30.71M30.99M30.99M
Other Non-Cash Items-36.72M-144.63M-745.84M95.74M-4.83M-162.82M-232.53M-18.24M-226.83M-73.33M
Working Capital Changes53M-35.42M-40.05M-55.72M-40.29M121.83M-43.77M-40.78M-53.6M43.81M
Cash from Investing+-2.42B-1.23B-976.52M324.5M-1.59B154.29M-724.14M-859.22M-184.66M-2.38B
Acquisitions (Net)-56.99M-6.44M-11.41M0-3.85M-286.82M-129.29M-83.65M-80.47M0
Purchase of Investments227.16M-1.73B-1.77B-873.32M-2.62B-861.05M-1.75B-792.92M00
Sale of Investments1000K1000K1000K1000K1000K1000K1000K1000K00
Other Investing-2.44B0-20.41M64.35M438.13M667.44M396.12M357.61M155.22M-1.77B
Cash from Financing+1.03B101.72M-671.33M-1.76B160.67M-1.3B-558.47M-283.93M-543.75M1.45B
Dividends Paid-1B-1.02B-827.28M-1.13B-1.16B-928.81M-686.89M-720.32M-723.56M-740.33M
Common Dividends-1B-1.02B-827.28M-1.13B-1.16B-928.81M-686.89M-720.32M-723.56M-740.33M
Debt Issuance (Net)1000K-1000K1000K-1000K1000K-1000K-1000K1000K1000K1000K
Share Repurchases000-1.37M00-96K-1.49M00
Other Financing-211.18M-342K-44.99M-38.78M-8.6M-25.94M-68.23M-48.44M-68.23M-64.33M
Net Change in Cash+-2.33M233.68M-205.35M-56.79M14.64M305.54M-255.04M-25.85M392.72M393.77M
Exchange Rate Effect-522K-852K312K-815K1000K1000K1000K-1000K1000K-1000K
Cash at Beginning55.35M53.02M286.71M188.25M131.46M146.1M451.64M196.6M170.75M563.46M
Cash at End53.02M286.71M81.36M131.46M146.1M451.64M196.6M170.75M563.46M957.23M
Free Cash Flow+1.16B1.11B1.01B918.73M877.14M921.53M593.15M666.09M860.46M725.78M
FCF Growth %0.1%-0.05%-0.09%-0.09%-0.05%0.05%-0.36%0.12%0.29%-0.16%
FCF / Revenue %----------

Key Ratios

Metric2015201620172018201920202021202220232024
FFO per Share4.188.8710.758.934.064.173.273.123.393.28
FFO Payout Ratio71.83%33.15%21.47%35.12%77.1%59.17%54.34%61.92%52.66%54.26%
NOI Margin57.09%58.12%58.41%54.85%53.25%48.89%45.44%44.71%43.06%42.59%
Net Debt / EBITDA6.15x3.61x3.59x2.91x6.39x6.79x7.38x7.30x7.20x6.54x
Debt / Assets50.34%48.03%47.07%47.53%50.26%50.59%49.46%51.69%55.35%52.47%
Interest Coverage2.27x1.33x1.39x1.95x1.90x1.26x0.96x1.03x0.72x1.13x
Book Value / Share28.8230.2230.4928.5928.5127.328.3327.3823.5326.01
Revenue Growth6.85%4.78%3.79%4.8%3.39%-2%0.86%7.87%8.93%9.48%

Revenue by Segment

2015201620172018201920202021202220232024
Senior Living Operations1.81B1.85B1.84B--2.2B2.27B2.65B2.96B3.37B
Senior Living Operations Growth-1.99%-0.22%---3.32%16.82%11.59%13.98%
Medical Office Building Operations600.68M643.37M760.96M--808.3M802.68M803.61M869.71M877.59M
Medical Office Building Operations Growth-7.11%18.28%----0.70%0.12%8.23%0.91%
Triple Net Leased Properties784.23M850.75M844.71M737.8M-695.26M653.82M598.15M619.21M622.05M
Triple Net Leased Properties Growth-8.48%-0.71%-12.66%---5.96%-8.51%3.52%0.46%
Resident Fees and Services---2.07B2.15B-----
Resident Fees and Services Growth----3.97%-----
Office Building and Other Services Revenue---3.3M3.41M-----
Office Building and Other Services Revenue Growth----3.24%-----
Office operations---776.01M------
Office operations Growth----------

Revenue by Geography

2015201620172018201920202021202220232024
UNITED STATES3.09B3.24B3.36B3.52B3.58B3.38B3.36B3.65B4B4.37B
UNITED STATES Growth-5.05%3.68%4.85%1.52%-5.50%-0.54%8.60%9.63%9.06%
CANADA173.78M174.83M186.05M192.35M266.95M389.2M434.86M449.09M464.77M526.58M
CANADA Growth-0.61%6.42%3.39%38.78%45.80%11.73%3.27%3.49%13.30%
UNITED KINGDOM26.17M26.34M26.42M--24.8M29.95M27.77M28.88M30.74M
UNITED KINGDOM Growth-0.64%0.30%---20.78%-7.26%3.99%6.43%

Frequently Asked Questions

Valuation & Price

Ventas, Inc. (VTR) has a price-to-earnings (P/E) ratio of 404.8x. This suggests investors expect higher future growth.

Growth & Financials

Ventas, Inc. (VTR) reported $5.56B in revenue for fiscal year 2024. This represents a 215% increase from $1.76B in 2011.

Ventas, Inc. (VTR) grew revenue by 9.5% over the past year. This is steady growth.

Yes, Ventas, Inc. (VTR) is profitable, generating $238.0M in net income for fiscal year 2024 (1.6% net margin).

Dividend & Returns

Yes, Ventas, Inc. (VTR) pays a dividend with a yield of 2.31%. This makes it attractive for income-focused investors.

Ventas, Inc. (VTR) has a return on equity (ROE) of 0.8%. This is below average, suggesting room for improvement.

Industry Metrics

Ventas, Inc. (VTR) generated Funds From Operations (FFO) of $1.58B in the trailing twelve months. FFO is the primary profitability metric for REITs.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.